SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001493152-21-012752
Filing Date
2021-05-24
Accepted
2021-05-24 17:23:55
Documents
8
Period of Report
2021-05-24
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 form8-k.htm 8-K 79369
2 ex2-1.htm EX-2.1 881500
3 ex10-1.htm EX-10.1 93566
4 ex10-2.htm EX-10.2 98814
5 ex10-3.htm EX-10.3 98390
6 ex99-1.htm EX-99.1 40278
7 image_009.jpg GRAPHIC 3155
8 image_010.jpg GRAPHIC 4416
  Complete submission text file 0001493152-21-012752.txt   1304110
Mailing Address 4851 TAMIAMI TRAIL N, SUITE 200 NAPLES FL 34103
Business Address 4851 TAMIAMI TRAIL N, SUITE 200 NAPLES FL 34103 239-302-1707
Enveric Biosciences, Inc. (Filer) CIK: 0000890821 (see all company filings)

IRS No.: 954484725 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38286 | Film No.: 21956244
SIC: 3674 Semiconductors & Related Devices